Compound containing tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure

The invention relates to a compound containing a tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure. Specifically, the compound disclosed by the invention has a structure as shown in a formula I, and the definitions of all groups and substituent groups are described in the specification. The i...

Full description

Saved in:
Bibliographic Details
Main Authors DING CHUNYONG, XIAO RUOXUAN, MA JING, ZHANG AO, XIAO XUANZHENG
Format Patent
LanguageChinese
English
Published 04.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to a compound containing a tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure. Specifically, the compound disclosed by the invention has a structure as shown in a formula I, and the definitions of all groups and substituent groups are described in the specification. The invention also discloses a preparation method of the compound and application of the compound in prevention and/or treatment of KRAS mutation related diseases. # imgabs0 # 本发明涉及含四氢吡唑并吡啶[3,4-d]嘧啶结构的化合物。具体地,本发明化合物具有式I所示结构,其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其在预防和/或治疗KRAS突变相关疾病方面的用途。#imgabs0#
AbstractList The invention relates to a compound containing a tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure. Specifically, the compound disclosed by the invention has a structure as shown in a formula I, and the definitions of all groups and substituent groups are described in the specification. The invention also discloses a preparation method of the compound and application of the compound in prevention and/or treatment of KRAS mutation related diseases. # imgabs0 # 本发明涉及含四氢吡唑并吡啶[3,4-d]嘧啶结构的化合物。具体地,本发明化合物具有式I所示结构,其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其在预防和/或治疗KRAS突变相关疾病方面的用途。#imgabs0#
Author XIAO XUANZHENG
ZHANG AO
MA JING
XIAO RUOXUAN
DING CHUNYONG
Author_xml – fullname: DING CHUNYONG
– fullname: XIAO RUOXUAN
– fullname: MA JING
– fullname: ZHANG AO
– fullname: XIAO XUANZHENG
BookMark eNrjYmDJy89L5WTwcc7PLcgvzUtRSM7PK0nMzMvMS1coSS0pSsyoTCnKL6gsSqzKzwHRmSmZeakK0cY6Cia6KbEKIJFciFhxSVFpcklpUSoPA2taYk5xKi-U5mZQdHMNcfbQTS3Ij08tLkhMTs1LLYl39jM0tDA0MjMwMXA0JkYNADDPOD8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 含四氢吡唑并吡啶[3,4-d]嘧啶结构的化合物
ExternalDocumentID CN118126040A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN118126040A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:06:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN118126040A3
Notes Application Number: CN202211543307
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240604&DB=EPODOC&CC=CN&NR=118126040A
ParticipantIDs epo_espacenet_CN118126040A
PublicationCentury 2000
PublicationDate 20240604
PublicationDateYYYYMMDD 2024-06-04
PublicationDate_xml – month: 06
  year: 2024
  text: 20240604
  day: 04
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies SHANGHAI JIAO TONG UNIVERSITY
RelatedCompanies_xml – name: SHANGHAI JIAO TONG UNIVERSITY
Score 3.6783235
Snippet The invention relates to a compound containing a tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure. Specifically, the compound disclosed by the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Compound containing tetrahydropyrazolopyridine [3, 4-d] pyrimidine structure
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240604&DB=EPODOC&locale=&CC=CN&NR=118126040A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzLnBxWkTwa3NV19KeLSjiGuGzJlIDKaJsEJbmOryPbXe0k754s-JVwgJBd-d5fkPgAuHR7Xaw3pEBELSahQLsGbbZVQ7iVurIRqmKCwTtRoP9H7gTsowPsqFsbkCf0yyRERUQniPTXyerp-xAqMb-X8mo-QNLlt9f3Azm_HWj3hoQdNP-x1gy6zGfNZZEePvo6vRNOdVu82YBPNaE-jIXxu6qiU6W-V0tqDrR7ONk73obB8K8EOW1VeK8F2J__wxm6OvfkBPGjo6iJIlnYvzwo7WKlMUVosxGwyXcziJUoybEeoj6T14lxZlIhXS1M-MlqWLfZzJg_hohX2WZvgsoY_PBiyaL0D5wiK48lYlsFCAy2p14XOY6ao5yY3Unmccu64NamQcgyVv-ep_Dd4Aruan8Yrip5CEdcnz1D_pvzcMO4bxkmL1g
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkXnVwXpk8WtTVdfirh0Y2rbDakyEClNk-IEt7FVZPvrvWSb80WfEi4Qkgu_u0tyHwAXFkvMWl1YBk-4MAjPbANvtlWDMCe1k4xndRUUFoT19hO579m9ArwvY2FUntAvlRwREZUi3nMlr0erRyxP-VZOrlgfScObVuR6-uJ2LNUTHrrXcJvdjtehOqUuDfXw0ZXxlWi6k-rtGqyjie1INDSfGzIqZfRbpbS2YaOLsw3yHSjM3spQosvKa2XYDBYf3thdYG-yC76EriyCpEn38nlhBy0XOUqLKR8PR9NxMkNJhm0f9ZHQXqxLjRj8VZOUjzltni32cyz24LzVjGjbwGXFPzyIabjagbUPxcFwIA5AQwMtNU0u85hlxLHTa5E5jDBm2TWRIeUQKn_PU_lv8AxK7SjwY_8ufDiCLclb5SFFjqGIaxUnqItzdqqY-A2BMY7J
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compound+containing+tetrahydropyrazolopyridine+%5B3%2C+4-d%5D+pyrimidine+structure&rft.inventor=DING+CHUNYONG&rft.inventor=XIAO+RUOXUAN&rft.inventor=MA+JING&rft.inventor=ZHANG+AO&rft.inventor=XIAO+XUANZHENG&rft.date=2024-06-04&rft.externalDBID=A&rft.externalDocID=CN118126040A